<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0036527" disease_type="Neoplastic Process" abbrv="">Ovarian metastases</z:e> from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), also known as <z:e sem="disease" ids="C0022790" disease_type="Neoplastic Process" abbrv="">Krukenberg Tumors</z:e> (KT), occur in about 3 per cent of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients and make up between 5 to 10 per cent of <z:hpo ids='HP_0000001'>all</z:hpo> colorectal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We sought to determine the effects of presentation of KT on treatment patterns and outcomes of patients diagnosed with KT </plain></SENT>
<SENT sid="2" pm="."><plain>Under institutional approval, 26 patients diagnosed with KT were identified from an institutional <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> database from 1994 to 2010 </plain></SENT>
<SENT sid="3" pm="."><plain>Twenty-two patients presented at the same time of their <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> diagnosis and four patients presented after diagnosis and treatment of their primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Demographic presentation and treatment patterns were similar between the two groups </plain></SENT>
<SENT sid="5" pm="."><plain>There was no overall survival difference between the two groups </plain></SENT>
<SENT sid="6" pm="."><plain>The median overall survival in the entire cohort was 27 months </plain></SENT>
<SENT sid="7" pm="."><plain>Factors affecting survival may include the extent of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> and age at time of presentation </plain></SENT>
<SENT sid="8" pm="."><plain>Patients who present with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> to the ovary alone may trend towards a better overall survival than patients who present with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> to additional other sites </plain></SENT>
</text></document>